Trials / Not Yet Recruiting
Not Yet RecruitingNCT07115459
Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring
Protocol for Developing and Validating a Multimodal Brain Monitoring-Based Prognostic Model for Neurocritical Patients: A Prospective, Observational, Multicenter Cohort Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 167 (estimated)
- Sponsor
- Xiangya Hospital of Central South University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to develop and validate a prognostic model for neurocritical patients using multimodal brain monitoring data. By combining data from various monitoring techniques such as EEG, TCD, and NIRS, this model will help predict 90-day outcomes (awake, comatose, or deceased) and support personalized treatment decisions. The study is observational and involves no experimental interventions.
Detailed description
This study is a prospective, observational, multicenter cohort study conducted in China. It focuses on neurocritical patients with acute brain injury, including large cerebral infarction, intracranial hemorrhage, subarachnoid hemorrhage, or severe traumatic brain injury. The study will collect multimodal data from EEG, TCD, and NIRS monitoring within 1-3 days of ICU admission. Machine learning algorithms will be used to develop a model predicting 90-day outcomes, categorized as awake, comatose, or deceased. The study population includes patients aged 18-80 years. Exclusion criteria include pre-existing severe neurological disorders, incomplete monitoring data, or withdrawal during the study period.
Conditions
- Acute Brain Injury Coma
- Neurocritical Care
- Cerebral Infarction
- Intracranial Hemorrhages
- Subarachnoid Hemorrhage
- Severe Traumatic Brain Injury
Timeline
- Start date
- 2025-08-15
- Primary completion
- 2026-08-15
- Completion
- 2026-11-15
- First posted
- 2025-08-11
- Last updated
- 2025-08-11
Source: ClinicalTrials.gov record NCT07115459. Inclusion in this directory is not an endorsement.